Citigroup Maintains Neutral on QuidelOrtho, Raises Price Target to $18

Benzinga Newsdesk www.benzinga.com Positive 61.6%

Neg 0% Neu 0% Pos 61.6%

Citigroup analyst Patrick Donnelly maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and raises the price target from $13 to $18.